OsstemImplant Co Ltd
KOSDAQ:048260
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
OsstemImplant Co Ltd
Free Cash Flow
OsstemImplant Co Ltd
Free Cash Flow Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Free Cash Flow | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
OsstemImplant Co Ltd
KOSDAQ:048260
|
Free Cash Flow
₩61.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Free Cash Flow
-₩8.3B
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Free Cash Flow
₩144.7B
|
CAGR 3-Years
76%
|
CAGR 5-Years
31%
|
CAGR 10-Years
132%
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Free Cash Flow
₩13B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Free Cash Flow
₩29.8B
|
CAGR 3-Years
69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Free Cash Flow
-₩11.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
OsstemImplant Co Ltd
Glance View
Osstem Implant Co., Ltd., a leading company in the dental implant industry, has carved out a significant niche for itself through innovation and strategic positioning. Founded in South Korea in 1997, it quickly ascended the ranks to become a dominant force in the global market. The company's business model revolves around the research, development, and manufacturing of dental implants and related products, targeting dental professionals and clinics worldwide. Osstem has differentiated itself by heavily investing in research and development, ensuring a steady stream of advanced products that meet the evolving needs of practitioners and patients alike. Their prowess in offering high-quality, cost-effective solutions has allowed the company to expand its presence across various continents, making it a recognized name in the dental healthcare industry. Operating in a highly competitive market, Osstem Implant combines quality manufacturing with robust marketing and educational programs. The firm's revenue streams flow primarily from the sale of its comprehensive dental implant systems and related equipment, supported by a network of training centers that have educated thousands of dental practitioners globally. These educational initiatives not only enhance customer loyalty but also serve to ensure that end-users are adept at utilizing their products effectively. Additionally, by maintaining a keen focus on emerging markets and leveraging strategic partnerships, the company continues to bolster its market share, thereby consolidating its financial health and sustainability. Through a commitment to innovation and quality, Osstem Implant not only thrives in an industry that demands precision but also contributes significantly to advancing dental care solutions worldwide.
See Also
What is OsstemImplant Co Ltd's Free Cash Flow?
Free Cash Flow
61.6B
KRW
Based on the financial report for Mar 31, 2023, OsstemImplant Co Ltd's Free Cash Flow amounts to 61.6B KRW.
What is OsstemImplant Co Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 1Y
-43%
Over the last year, the Free Cash Flow growth was -43%.